Federal government appeals approval of $55M sale of Hahnemann's residency program assets
September 12, 2019 at 16:52 PM EDT
The appeal shifts the controversial sale's battleground to the U.S. District Court in Delaware.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|